A novel oncolytic adenovirus based on simian adenovirus serotype 24

Among the oncolytic virotherapy, an emerging treatment for tumor, adenoviruses are widely used at present in preclinical and clinical trials. Traditionally, oncolytic adenoviruses were developed based on the human adenovirus serotype 5 (AdHu5). However, AdHu5 has the drawbacks of preexisting anti-Ad...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Tao, Song, Yufeng, Zhang, Yan, Zhang, Chao, Yin, Jieyun, Chi, Yudan, Zhou, Dongming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5432303/
https://www.ncbi.nlm.nih.gov/pubmed/28460470
http://dx.doi.org/10.18632/oncotarget.15845

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5432303/
https://www.ncbi.nlm.nih.gov/pubmed/28460470
http://dx.doi.org/10.18632/oncotarget.15845

Ejemplares similares